232 related articles for article (PubMed ID: 9784551)
1. CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge.
Brown WC; Shkap V; Zhu D; McGuire TC; Tuo W; McElwain TF; Palmer GH
Infect Immun; 1998 Nov; 66(11):5406-13. PubMed ID: 9784551
[TBL] [Abstract][Full Text] [Related]
2. The repertoire of Anaplasma marginale antigens recognized by CD4(+) T-lymphocyte clones from protectively immunized cattle is diverse and includes major surface protein 2 (MSP-2) and MSP-3.
Brown WC; Zhu D; Shkap V; McGuire TC; Blouin EF; Kocan KM; Palmer GH
Infect Immun; 1998 Nov; 66(11):5414-22. PubMed ID: 9784552
[TBL] [Abstract][Full Text] [Related]
3. CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strains.
Brown WC; Palmer GH; Lewin HA; McGuire TC
Infect Immun; 2001 Nov; 69(11):6853-62. PubMed ID: 11598059
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginale.
Tuo W; Palmer GH; McGuire TC; Zhu D; Brown WC
Infect Immun; 2000 Jan; 68(1):270-80. PubMed ID: 10603398
[TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.
Brown WC; McGuire TC; Mwangi W; Kegerreis KA; Macmillan H; Lewin HA; Palmer GH
Infect Immun; 2002 Oct; 70(10):5521-32. PubMed ID: 12228278
[TBL] [Abstract][Full Text] [Related]
7. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
[TBL] [Abstract][Full Text] [Related]
8. Identification of IgG2-specific antigens in Mexican Anaplasma marginale strains.
Barigye R; García-Ortiz MA; Rojas Ramírez EE; Rodríguez SD
Ann N Y Acad Sci; 2004 Oct; 1026():84-94. PubMed ID: 15604474
[TBL] [Abstract][Full Text] [Related]
9. Heterologous strain challenge of cattle immunized with Anaplasma marginale outer membranes.
Palmer GH; Munodzana D; Tebele N; Ushe T; McElwain TF
Vet Immunol Immunopathol; 1994 Sep; 42(3-4):265-73. PubMed ID: 7810060
[TBL] [Abstract][Full Text] [Related]
10. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
[TBL] [Abstract][Full Text] [Related]
11. Immunization of cattle with Anaplasma marginale derived from tick cell culture.
Kocan KM; Halbur T; Blouin EF; Onet V; de la Fuente J; Garcia-Garcia JC; Saliki JT
Vet Parasitol; 2001 Dec; 102(1-2):151-61. PubMed ID: 11705661
[TBL] [Abstract][Full Text] [Related]
12. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
[TBL] [Abstract][Full Text] [Related]
13. Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.
Brown WC; McGuire TC; Zhu D; Lewin HA; Sosnow J; Palmer GH
J Immunol; 2001 Jan; 166(2):1114-24. PubMed ID: 11145692
[TBL] [Abstract][Full Text] [Related]
14. Expression of major surface protein 2 variants with conserved T-cell epitopes in Anaplasma centrale vaccinates.
Shkap V; Molad T; Brayton KA; Brown WC; Palmer GH
Infect Immun; 2002 Feb; 70(2):642-8. PubMed ID: 11796593
[TBL] [Abstract][Full Text] [Related]
15. Cooperation of PD-1 and LAG-3 Contributes to T-Cell Exhaustion in Anaplasma marginale-Infected Cattle.
Okagawa T; Konnai S; Deringer JR; Ueti MW; Scoles GA; Murata S; Ohashi K; Brown WC
Infect Immun; 2016 Oct; 84(10):2779-90. PubMed ID: 27430272
[TBL] [Abstract][Full Text] [Related]
16. Induction of protective immunity by using Anaplasma marginale initial body membranes.
Tebele N; McGuire TC; Palmer GH
Infect Immun; 1991 Sep; 59(9):3199-204. PubMed ID: 1715323
[TBL] [Abstract][Full Text] [Related]
17. The hypervariable region of Anaplasma marginale major surface protein 2 (MSP2) contains multiple immunodominant CD4+ T lymphocyte epitopes that elicit variant-specific proliferative and IFN-gamma responses in MSP2 vaccinates.
Brown WC; Brayton KA; Styer CM; Palmer GH
J Immunol; 2003 Apr; 170(7):3790-8. PubMed ID: 12646645
[TBL] [Abstract][Full Text] [Related]
18. Immunization of cattle with a 36-kilodalton surface protein induces protection against homologous and heterologous Anaplasma marginale challenge.
Palmer GH; Oberle SM; Barbet AF; Goff WL; Davis WC; McGuire TC
Infect Immun; 1988 Jun; 56(6):1526-31. PubMed ID: 3372018
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.
de la Fuente J; Kocan KM; Garcia-Garcia JC; Blouin EF; Claypool PL; Saliki JT
Vet Microbiol; 2002 Oct; 89(2-3):239-251. PubMed ID: 12243900
[TBL] [Abstract][Full Text] [Related]
20. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
